A clinical trial of NanoAgCide hand sanitizer on Coronavirus patients.
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/10/028688
- Lead Sponsor
- WeInnovate Biosolutions Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- Not specified
- Target Recruitment
- 0
1. Male or Female aged 18 to 80 years (both inclusive) of age tested SARS-CoV-2 positive within last
8 days of study enrolment.
2. Patients willing to sign written informed consent and are ready to comply to study procedure.
3. SARS-CoV-2 positive asymptomatic or symptomatic patients who are under institutional
quarantine.
1. Patients requiring emergency treatment during enrolment.
2. Patients on ventilator support.
3. Pregnant or lactating woman.
4. Subjects with history of sun burn on hands.
5. Subjects with history of skin disorders or on medication for the same: Eczema, Urticaria, Psoriasis,
Herpes, skin cancer, Lupus, Vitiligo, Fungal infection, Candidiasis.
6. Subjects on treatment of any degree burns.
7. Any kind of psychiatric disorder or a condition in the opinion of the investigator may hinder
communication with the research team.
8. Inability of the subject to cooperate or communicate with the research team.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method